GlucoTrack (Nasdaq:GCTK) announced today that its second-generation glucose monitor device has shown promising results in analyses. Rutherford, New Jersey-based GlucoTrack — formerly known as Integrity Applications (Nasdaq:IGAP) — earlier this year completed lab testing of the non-invasive GlucoTrack 2.0 clinical prototype system and has observed better-than-expected accuracy and performance with the technology. Get the full […]
Integrity Applications
Integrity Applications changes company name to GlucoTrack
Integrity Applications (Nasdaq:IGAP) announced today that it completed the change of its corporate name to GlucoTrack. Rutherford, New Jersey-based GlucoTrack confirmed the change of its ticker symbol on the Nasdaq capital market to “GCTK,” which was made effective at the commencement of trading today, March 14, 2022. Get the full story at our sister site, Drug […]
Integrity Applications inks exclusive Dutch distro deal for GlucoTrack
Integrity Applications said today it inked an exclusive distribution deal with MediReva B.V. to distribute its GlucoTrack non-invasive glucose measuring device in the Netherlands, effective December 22. Integrity Application’s flagship GlucoTrack is a sensor that clips to the earlobe and uses a combination of metrics to determine blood glucose based on physiological changes in the body. […]
Integrity Applications raises $12m
Integrity Applications said yesterday it raised $12 million in a private placement offering to support its GlucoTrack non-invasive glucose measuring device. In the placement, accredited investors purchased units consisting of a single share of Series C perferred stock, convertible into common shares at $4.50 per share, along with 2 warrants to purchase shares of common […]
ADA 2017 Roundup: J&J inks dev deal with Qualcomm, launches next-gen OneTouch Reveal app
Johnson & Johnson (NYSE:JNJ) is continuing to develop its diabetes offerings, with its LifeScan business partnering with Qualcomm Life to improve its OneTouch Verio Flex blood glucose meters and launching a next-gen version of its OneTouch Reveal mobile app. The company will be partnering with the Qualcomm subsidiary to streamline wireless data capture from LifeScan’s […]
Avita Medical taps ex-Novartis exec Perry for CEO as it shifts focus to US | Personnel Moves June 9, 2017
Avita Medical (ASX:AVH) said last week it tapped former Novartis (NYSE:NVS) global biz dev & licensing chief scientific officer Dr. Michael Perry as its new chief executive officer, replacing resigning CEO Adam Kelliher. Dr. Perry served as a non-exec director of Avita since Feb 2013, according to the company, and held positions with Novartis including chief scientific […]
Hook to step down as Integer CEO | Personnel Moves | March 31 , 2017
Integer Holdings (NYSE:ITGR) said this week that current CEO Thomas Hook has stepped down as the company’s president and CEO, effective immediately, with Joseph Dziedzic taking over as interim prez & CEO. Hook will stay on the Frisco, Texas-based company’s board until the company’s 2017 annual meeting of stockholders, but will not seek re-election. Dziedzic is currently a […]
HeartWare taps ex-Medtronic exec Oesterle for board | Personnel Moves
HeartWare International (NSDQ:HTWR) is looking to get in on Dr. Stephen Oesterle, an Ex-Medtronic (NYSE:MDT) exec who moved to the venture capital firm New Enterprise Associates last Sept., saying this week that it expanded its board to accommodate Oesterle. Oesterle will officially come aboard on Jan. 18, and his appointment included an expansion to HeartWare’s board […]
Integrity Applications preps for clinical trial
Integrity Applications said today it filed pre-submission documents with the FDA for a proposed clinical trial of its GlucoTrack non-invasive blood glucose monitor. The company’s blood glucose sensors use ultrasonic, electromagnetic and thermal scans rather than blood tests, according to the company. Integrity Application’s flagship GlucoTrack is a sensor that clips to the earlobe and […]